“…Recent studies have demonstrated that miR-218 is downregulated in various types of cancer, including cervical cancer, gastric cancer, lung cancer, colon cancer, prostate cancer, and bladder cancer (Davidson et al, 2010;Song et al, 2010;Tie et al, 2010;Leite et al, 2011;Uesugi et al, 2011;Li et al, 2012a;Li et al, 2012b;Chiyomaru et al, 2012;He et al, 2012). However, the level of miR0218 expression, and its clinical significance in pancreatic cancer, remains to be investigated.…”